Cytovance Biologics Capacity Update July 2025: Large Molecule Drug Substance

Cytovance Biologics is a trusted CDMO partner that is large enough to support you at every stage, yet small enough to stay agile and provide your program with the care it deserves. For 20 years, Team Cytovance has supported programs from development to cGMP clinical and commercial manufacturing. Cytovance is a leader in the development and manufacturing of microbial and mammalian-expressed proteins. With 320+ large molecules having entered global clinical trials, our expertise includes full-length, fragment and multi-specific antibodies, fusion proteins, enzymes, cytokines, hormones, virus-like particle vaccines, and other complex molecules.

Thomas Kohl, Director of Business Development, shares the company’s microbial and mammalian capabilities as well as their available capacity. Centrally located in the United States, with a decades-long history in biologics development and manufacturing, Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.